WASHINGTON (Reuters) – The U.S. Food and Drug Administration is aiming to give full approval for the Pfizer COVID vaccine by early September, the New York Times reported on Tuesday, citing people involved in the effort.
(Reporting by Eric Beech; Editing by Sandra Maler)